InscoV, Exclusive Distributor Agreement with UK Probiotics "Entering the Health Supplement Market"

[Asia Economy Reporter Hyunseok Yoo] InscoBee announced on the 15th that it has signed an exclusive domestic distribution agreement for two health food products effective in preventing cardiovascular diseases with Probiotics, a subsidiary of Optibiotics, a renowned British biotechnology company.

Optibiotics, listed on the UK stock market in 2014, is a biotechnology company specializing in the research and development of microbial strains used as raw materials for pharmaceuticals and health foods. By acquiring the exclusive domestic distribution rights for two cardiovascular disease prevention health food products from Probiotics, Optibiotics' specialized subsidiary for lactic acid bacteria development, InscoBee is expected to successfully enter the domestic health food market.

The two products exclusively imported and sold domestically by InscoBee are ‘Cholbiome’ and ‘Cholbiome X3’. Both products help maintain healthy cholesterol levels through the LPLDL strain. In particular, ‘Cholbiome X3’ contains additional Vitamin B3 and Monacolin K3 along with the LPLDL strain, which protects the bacteria from stomach acid and can rapidly reduce cholesterol levels, drawing attention.

The LPLDL lactic acid bacteria, patented by Probiotics, is known to have excellent effects in preventing cardiovascular diseases by reducing cholesterol and blood pressure. Young Probiotics has been conducting research in this field since 2012 and has also completed the rigorous US FDA GRAS (Generally Recognized As Safe) approval.

The US FDA GRAS certification system involves FDA experts evaluating the safety of the substance under intended usage conditions through a stringent certification and review process. It is a system that approves substances deemed safe for consumption as food.

Following this exclusive distribution agreement, InscoBee will actively promote domestic sales. The approval process for the LPLDL strain with the Korean Ministry of Food and Drug Safety is underway, and negotiations are ongoing with various distribution channels such as home shopping, online malls, H&B stores, and personal health care shops to enable immediate sales upon approval.

An InscoBee official stated, “Since ‘Cholbiome’ and ‘Cholbiome X3’ are being introduced to the domestic market for the first time, we are thoroughly preparing to ensure their successful establishment in the market,” adding, “Starting with this exclusive distribution agreement, we will diversify the import and distribution of globally renowned health food products.”

This content was produced with the assistance of AI translation services.